NASOPHARYNGEAL CARCINOMA (NPC)
Clinical trials for NASOPHARYNGEAL CARCINOMA (NPC) explained in plain language.
Never miss a new study
Get alerted when new NASOPHARYNGEAL CARCINOMA (NPC) trials appear
Sign up with your email to follow new studies for NASOPHARYNGEAL CARCINOMA (NPC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Donor cells join fight against nasopharyngeal cancer recurrence
Disease control Not yet recruitingThis early-phase trial tests whether adding natural killer (NK) cells from healthy donors to standard chemoradiotherapy can lower the chance of cancer returning in 31 people with advanced nasopharyngeal cancer. The study first finds the safest dose of NK cells, then checks if the…
Matched conditions: NASOPHARYNGEAL CARCINOMA (NPC)
Phase: PHASE1, PHASE2 • Sponsor: Singapore General Hospital • Aim: Disease control
Last updated May 13, 2026 15:59 UTC
-
New drug may shield cancer patients from dangerous platelet drop
Disease control Not yet recruitingThis study tests whether the drug hetrombopag can prevent severe low platelet counts caused by chemotherapy in people with nasopharyngeal carcinoma. About 35 patients who had low platelets after their last chemo round will receive hetrombopag during their next cycles. The goal is…
Matched conditions: NASOPHARYNGEAL CARCINOMA (NPC)
Phase: PHASE2 • Sponsor: Fujian Cancer Hospital • Aim: Disease control
Last updated May 11, 2026 20:50 UTC
-
New drug aims to stop throat cancer from coming back
Disease control Not yet recruitingThis study tests a new drug, Becotatug vedotin, against a standard chemotherapy pill (capecitabine) to see which is better at preventing cancer from returning in people with advanced nasopharyngeal cancer. About 218 adults who have already completed standard chemoradiation will b…
Matched conditions: NASOPHARYNGEAL CARCINOMA (NPC)
Phase: PHASE2 • Sponsor: Kai Hu • Aim: Disease control
Last updated May 11, 2026 20:41 UTC
-
New hope for Tough-to-Treat nasopharyngeal cancer: ivonescimab trial launches
Disease control Not yet recruitingThis study tests a drug called ivonescimab in 42 people with advanced nasopharyngeal cancer that has stopped responding to standard immunotherapy and chemotherapy. The goal is to see if the drug can shrink tumors or slow the cancer's growth. Participants will receive the drug int…
Matched conditions: NASOPHARYNGEAL CARCINOMA (NPC)
Phase: PHASE2 • Sponsor: National University Hospital, Singapore • Aim: Disease control
Last updated May 06, 2026 16:14 UTC
-
New drug duo shows promise for Tough-to-Treat throat cancer
Disease control Not yet recruitingThis study tests whether combining two drugs, scipibaimab and tislelizumab, can shrink tumors or slow cancer growth in people with advanced nasopharyngeal cancer that got worse after standard first treatment. About 37 adults aged 18-75 will receive the combo. The goal is to see h…
Matched conditions: NASOPHARYNGEAL CARCINOMA (NPC)
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated May 01, 2026 15:58 UTC
-
Simple nose procedure may prevent severe radiation damage in recurrent cancer patients
Prevention Not yet recruitingThis study tests whether removing a thin membrane that forms in the nose/throat after repeat radiation can prevent tissue death (necrosis) in people with recurrent nasopharyngeal cancer. About 40 adults who have had a second round of radiation will undergo a scope-based removal p…
Matched conditions: NASOPHARYNGEAL CARCINOMA (NPC)
Phase: NA • Sponsor: Jiangxi Provincial Cancer Hospital • Aim: Prevention
Last updated May 12, 2026 13:41 UTC
-
Taurine may soothe radiation mouth sores in cancer patients
Symptom relief Not yet recruitingThis study tests if taurine, a natural substance, can prevent or reduce severe mouth sores caused by radiation treatment in people with nasopharyngeal cancer. About 130 patients will either receive taurine or standard care during their radiation therapy. The goal is to see if tau…
Matched conditions: NASOPHARYNGEAL CARCINOMA (NPC)
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Symptom relief
Last updated May 11, 2026 20:49 UTC
-
New imaging technique may sharpen cancer staging and immunotherapy predictions
Knowledge-focused Not yet recruitingThis study will test whether two types of PET/CT scans can more accurately stage nasopharyngeal cancer and predict how well patients will respond to immunotherapy before treatment. Researchers will observe 732 adults with newly diagnosed cancer, measuring tumor activity on scans …
Matched conditions: NASOPHARYNGEAL CARCINOMA (NPC)
Sponsor: The First Affiliated Hospital of Xiamen University • Aim: Knowledge-focused
Last updated May 15, 2026 11:57 UTC
-
Immune secrets of nasopharyngeal cancer revealed in new study
Knowledge-focused Not yet recruitingThis study looks at how the immune system interacts with nasopharyngeal cancer before and after immunotherapy. Researchers will analyze tissue samples from 600 patients to find key cells that predict whether treatment works. They also use advanced techniques to understand why som…
Matched conditions: NASOPHARYNGEAL CARCINOMA (NPC)
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Knowledge-focused
Last updated May 07, 2026 18:41 UTC